Market Overview
The domestic animal vaccine awareness and education is one of the key factors driving the global animal anti rabies vaccines market. For instance, in September 2017, Morris Animal Foundation funded for animal rabies vaccines studies. The vaccine has a positive impact on overall canine health as well, and is associated with a decrease in death from all causes. The increasing government initiative for anti rabies vaccination is driving the global animal anti rabies vaccine market. For instance, in January 2016, 80,000 doses of animal rabies vaccines were delivered to Tunisia with the support of the European Union by OIE regional vaccine banks. In February 2016, 1,701,150 doses of animal rabies vaccines were delivered to the Philippines. These deliveries raise the number of doses purchased by a beneficiary country in collaboration with WHO through the OIE rabies vaccine bank to almost 8 million.
Market Dynamics
Drivers
- Domestic animal vaccination, Awareness and education
- Increasing government initiative for anti rabies vaccination
Restraints
- Side-effects of rabies vaccine and extralabel use
Domestic animal vaccination, Awareness and education
The domestic animal vaccine awareness and education is one of the key factors driving the global animal anti rabies vaccines market. Multiple vaccines are licensed for use in domestic animal species. Vaccines available include inactivated and modified-live virus vectored products, products for IM and SC administration, products with durations of immunity for periods of 1 to 3 years, and products with various minimum ages of vaccination. Recommended vaccination procedures are specified in Part II of this compendium; animal rabies vaccines licensed by the USDA and marketed in the United States Veterinary Law. Essential components of rabies prevention and control include ongoing public education, responsible pet ownership, routine veterinary care and vaccination, and professional continuing education. Most animal exposures to rabies can be prevented by raising awareness concerning rabies transmission routes, the importance of avoiding contact with wildlife, and the need for appropriate veterinary care. In September 2017, Morris Animal Foundation was funded for animal rabies vaccines studies. The vaccine has a positive impact on overall canine health as well, and is associated with a decrease in death from all causes.
Geographical Analysis
The North America animal antirabies vaccine market is valued at USD 380.3 Mn in 2019 and is estimated to grow at a CAGR of 4.92% over the forecast period to reach a USD *** Mn by 2027. The U.S. holds 75.2% of market share in 2017, and is expected to increase by 76.0% by 2025, for the global animal antirabies vaccine market. The collective revenue of North America is expected to generate USD *** Mn by 2027. The United States, Canada, and Mexico is included in the scope of the North America animal antirabies vaccine market. The key players of the North America animal antirabies vaccine market are Merck Animal Health, Zoetis Inc., and Elanco Animal Health. The strategic competitiveness between companies is one of the key factors driving the global animal antirabies vaccine market. For instance in October 2016, Elanco Animal Health acquired Boehringer Ingelheim Vetmedica Inc. portfolio of U.S. canine, feline and rabies vaccines, as well as a fully integrated manufacturing and R&D site. The aqusition was valued at USD 885 million including the estimated cost of acquired inventory. The expansion of production sites by the market player is driving the global Animal Antirabies Vaccine market. For instance, in January 2017, IDT Biologika, a world leader in vaccines, established a new organization to serve the animal health needs of veterinarians, farmers and government agencies in the Americas. IDT Animal Health Americas will provide an innovative range of high-quality autogenous, wildlife and commercial vaccines and diagnostic solutions for use in animals. RABORAL V-RG is approved for immunization of raccoons and coyotes, two of the most significant wildlife carriers of rabies in North America.
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
